Treatment of Early Glottic cancer with Transoral Laser Microsurgery: An Australian Experience.

Indian J Otolaryngol Head Neck Surg

Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, NSW Australia.

Published: June 2023

Introduction: Early laryngeal carcinomas may be treated by transoral laser microsurgery (TLM) or external beam radiotherapy. We review our experience of surgical treatment of laryngeal pre-malignant and malignant lesions over the past 15 years in a high-volume head neck unit.

Methods: A review of a prospective patient database of patients with laryngeal SCC, who were treated with CO TLM between 2004 and 2019 was carried out.

Results: 83 patients with a mean age of 67.7 (SD: 10.6) years underwent primary curative TLM for T1a/b SCC. 5-year overall survival was 93.2% (95%CI 86.9-100%), disease free survival was 86.0% (95%CI 78.1-94.6%), locoregional control was 91.2% (95%CI: 85.1-97.7%) and larynx preservation rate of 95.1% at 5 years.

Conclusion: TLM is an excellent treatment modality for T1 early glottic SCC, with excellent locoregional control and disease-free survival. It is minimally invasive, outpatient-based, and cost-effective procedure preserving upper aerodigestive tract dysfunction for all activities of daily living.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235397PMC
http://dx.doi.org/10.1007/s12070-022-03392-8DOI Listing

Publication Analysis

Top Keywords

early glottic
8
transoral laser
8
laser microsurgery
8
locoregional control
8
treatment early
4
glottic cancer
4
cancer transoral
4
microsurgery australian
4
australian experience
4
experience introduction
4

Similar Publications

Purpose: Over the last 40 years, there has been an unusual trend where, even though there are more varied treatments, survival rates have not improved much. Our study used survival analysis and machine learning (ML) to investigate this odd situation and to improve prediction methods for treating non-metastatic LSCC.

Methods: The surveillance, epidemiology and end results (SEER) database provided the data used for this study's analysis.

View Article and Find Full Text PDF

From Prone to Prepared: Airway Management in a Patient With Penetrating Thoracic Trauma.

Cureus

December 2024

Anesthesiology, Unidade Local de Saúde de São José, Lisbon, PRT.

Perioperative and critical care management following penetrating thoracic trauma represents a complex challenge. Those who survive the early trauma approach and reach the hospital alive often remain in critical condition, with cardiocirculatory complications and major pulmonary injuries. Additional difficulty arises from the presence of a weapon , particularly in a dorsal location, which limits patient positioning, and the safe manipulation of both the weapon and the patient.

View Article and Find Full Text PDF

[Analysis of clinical characteristics of amyotrophic lateral sclerosis patients initially diagnosed with abnormal laryngeal function].

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi

December 2024

Department of Voice Medicine, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen Key Laboratory of Voice Medicine, Xiamen361004, China.

To study the laryngeal functional characteristics of patients with amyotrophic lateral sclerosis (ALS)disease diagnosed at the voice clinic. A retrospective analysis(case series study) was conducted on the laryngeal functional characteristics of 7 patients [2 males, 5 females, age ranged from 43 to 76(60.85±13.

View Article and Find Full Text PDF

The recommended treatment for early glottic cancer is trans-oral laser microsurgery, with excellent oncological and functional outcomes. The aim of this study is to evaluate oncological and functional outcomes in patients who underwent monolateral type III laser cordectomy for early glottic cancer. A total of 104 patients were enrolled.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!